|
DSM receives grant of US Department of Energy for biotechnology research
(Market Wire Via Thomson Dialog NewsEdge) HEERLEN, NETHERLANDS, February 27 / MARKET WIRE/ --
Royal DSM N.V., the global Life Sciences and Materials Sciences
company headquartered in the Netherlands, has received a grant from
the US Department of Energy for a technical consortium on an
innovative biotechnological approach of bioproducts and biofuels.
The grant will fund an extensive enzyme development program which
will focus on finding applications in cellulose-based biorefineries
for the production of bio-based products, including biofuels. The
research will be carried out by a technical consortium in which DSM
will be the lead partner. The other participants in this proposed
project include Abengoa Bioenergy New Technologies, Los Alamos
Laboratory and Sandia National Laboratory. An important part of the
development work will be executed in the US and the program will run
for four years.
The grant fits in with the extensive White Biotech program that DSM
is running as one of its Emerging Business Areas with the aim of
becoming a company fully focused on Life Sciences and Materials
Sciences in line with its strategy Vision 2010. It will enlarge DSM's
capabilities as a leader in biotechnology.
"The focus of this funded program is right at the heart of our White
Biotechnology strategy to create practical solutions for the
biorefineries of the future, using feedstocks that are not in
conflict with food and feed supplies," says Volkert Claassen, DSM's
Vice President White Biotechnology. "We also recognize that it will
require solid industry and institutional partnerships in order to
fully realize the potential of bio-based manufacturing, such as the
partners in this particular program."
Commercially feasible
Global developments across all technology platforms in bio-conversion
of cellulosic feedstocks are still at an early stage. In order to
create and utilize commercially feasible solutions, the integration
of technologies across the complete value chain and the manufacturing
and entrepreneurial skills of companies such as of DSM and Abengoa
are essential. This collaboration allows DSM to more rapidly develop
and test technology at semi-commercial and full commercial scale in
existing and pilot plants.
DSM's main field of interest in this program is to develop the
technical skills for cellulosic biomass hydrolysis. After completion
of this program DSM will decide upon further research and partners to
collaborate within this field.
Consortium partners
DSM strives to be a leading integrated technology provider for the
so-called second generation processes for biofuel and bio-based
chemical production. DSM brings over a hundred years of experience in
enzymes, yeast technology and industrial fermentation, and is unique
in its ability to integrate these competencies of chemical
engineering and biotechnology within a single entity. Abengoa brings
many years of manufacturing, knowledge and processing capabilities.
DSM and its industry, institutional and academic partners ultimately
aim to provide practical solutions across the entire biorefining
technology platform with particular focus on feedstock pretreatment,
enzymatic hydrolysis and advanced fermentation organism technologies.
DSM - the Life Sciences and Materials Sciences Company
DSM creates innovative products and services in Life Sciences and
Materials Sciences that contribute to the quality of life. DSM's
products and services are used globally in a wide range of markets
and applications, supporting a healthier, more sustainable and more
enjoyable way of life. End markets include human and animal nutrition
and health, personal care, pharmaceuticals, automotive, coatings and
paint, electrics and electronics, life protection and housing. DSM
has annual sales of almost EUR 8.8 billion and employs some 23,000
people worldwide. The company is headquartered in the Netherlands,
with locations on five continents. DSM is listed on Euronext
Amsterdam. More information: www.dsm.com.
For more information:
DSM Corporate Communications DSM Investor Relations
Elvira Luykx Hans Vossen
tel. +31 (0) 45 tel. +31 (0) 45 5782864
5782035 fax +31 (0) 45 5782595
fax +31 (0) 45 e-mail
5740680 investor.relations@dsm.com
e-mail media.relations@dsm.com
Copyright ? Hugin AS 2008. All rights reserved.
Copyright ? 2008 Market Wire, Incorporated
[ Back To TMCnet.com's Homepage ]
|
INDUSTRIES
INDUSTRIES
